Skip to content
Tech News
clear
Topics: Today This Week This Month This Year
31.
This scientist found a new trick of the immune system by digging through cellular rubbish (feeds.nature.com)
32.
Adenosine on the common path of rapid antidepressant action: The coffee paradox (news.ycombinator.com)
33.
Will blockbuster obesity drugs revolutionize addiction treatment? (feeds.nature.com)
34.
From blood sugar to brain relief: GLP-1 therapy slashes migraine frequency (news.ycombinator.com)
35.
Low Doses of Ozempic-Like Drug Can Counteract Aging in Older Mice, Study Finds (futurism.com)
36.
RFK Jr. Wants to Link Antidepressants Like SSRIs to Mass Shootings. Experts Aren’t Buying It (gizmodo.com)
37.
Weight-Loss Drug Zepbound Is Being Tested as a Treatment for Long Covid (wired.com)
38.
Semaglutide Helps Your Heart Even If the Scale Doesn’t Budge, Study Shows (gizmodo.com)
39.
Two People Almost Drown After Asking ChatGPT When Low Tide Was (futurism.com)
40.
Food Noise: What It Sounds Like, How to Ease It and Ozempic Precautions (cnet.com)
41.
Powered by India’s small businesses, UK fintech Tide becomes a TPG-backed unicorn (techcrunch.com)
42.
Dietitian Tips for Fighting Food Noise -- Without Using Semaglutide (cnet.com)
43.
How to Fight Food Noise if It’s Taking Over Your Life, Both IRL and Online (cnet.com)
44.
Ozempic Maker Novo Nordisk Freezes Hiring Amid Ongoing Struggles (gizmodo.com)
45.
Tidewave Web: in-browser coding agent for Rails and Phoenix (news.ycombinator.com)
46.
Ozempic shows anti-aging effects in trial (news.ycombinator.com)
47.
Ozempic Shows Anti-Aging Effects in Trial, Reversing Biological Age by 3.1 Years (news.ycombinator.com)
48.
This Once-a-Month Ozempic Rival Just Delivered Big Results (gizmodo.com)
49.
Ozempic Might Be a Dementia Buster, Too (gizmodo.com)
50.
Something Comically Bad Just Happened to the Inventor of Ozempic (futurism.com)
51.
Toxic Proteins for Drug Discovery (news.ycombinator.com)
52.
‘Uber for Getting Off Antidepressants’ Launches in the US (wired.com)
53.
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage (cnbc.com)
54.
Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage (cnbc.com)
Today's top topics: apple amazon google openai nvidia android meta android authority chatgpt samsung
View all today's topics →